- Home
- SPFI vs MGTX Comparison
SPFI vs MGTX Comparison
Compare SPFI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPFI
- MGTX
- Stock Information
- Founded
- SPFI 1941
- MGTX 2015
- Country
- SPFI United States
- MGTX United States
- Employees
- SPFI N/A
- MGTX N/A
- Industry
- SPFI Major Banks
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPFI Finance
- MGTX Health Care
- Exchange
- SPFI Nasdaq
- MGTX Nasdaq
- Market Cap
- SPFI 662.8M
- MGTX 670.2M
- IPO Year
- SPFI 2019
- MGTX N/A
- Fundamental
- Price
- SPFI $39.76
- MGTX $7.51
- Analyst Decision
- SPFI Buy
- MGTX Strong Buy
- Analyst Count
- SPFI 3
- MGTX 2
- Target Price
- SPFI $41.67
- MGTX $24.00
- AVG Volume (30 Days)
- SPFI 43.4K
- MGTX 325.1K
- Earning Date
- SPFI 10-22-2025
- MGTX 08-14-2025
- Dividend Yield
- SPFI 1.49%
- MGTX N/A
- EPS Growth
- SPFI 19.09
- MGTX N/A
- EPS
- SPFI 3.20
- MGTX N/A
- Revenue
- SPFI $199,001,000.00
- MGTX $37,917,000.00
- Revenue This Year
- SPFI $13.41
- MGTX $145.67
- Revenue Next Year
- SPFI $6.10
- MGTX $167.61
- P/E Ratio
- SPFI $12.63
- MGTX N/A
- Revenue Growth
- SPFI 7.49
- MGTX 366.84
- 52 Week Low
- SPFI $30.01
- MGTX $3.86
- 52 Week High
- SPFI $42.38
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- SPFI 49.57
- MGTX 46.65
- Support Level
- SPFI $39.62
- MGTX $7.39
- Resistance Level
- SPFI $40.93
- MGTX $7.91
- Average True Range (ATR)
- SPFI 1.01
- MGTX 0.36
- MACD
- SPFI -0.17
- MGTX 0.01
- Stochastic Oscillator
- SPFI 7.51
- MGTX 39.78
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.